| Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations |
23 |
| Decreasing prevalence and severity of cerebral palsy in Norway among children born 1999 to 2010 concomitant with improvements in perinatal health |
13 |
| ATP1A3-related disorders: An update |
13 |
| Deep brain stimulation for dystonia due to cerebral palsy: A review |
13 |
| Diagnosis of tuberous sclerosis complex in the fetus |
12 |
| Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes |
11 |
| Understanding the relationship between brain and upper limb function in children with unilateral motor impairments: A multimodal approach |
11 |
| Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience |
9 |
| Transcranial direct current stimulation and constraint-induced therapy in cerebral palsy: A randomized, blinded, sham-controlled clinical trial |
8 |
| Treatment of electrical status epilepticus in sleep: Clinical and EEG characteristics and response to 147 treatments in 47 patients |
8 |
| Clinical and genetic spectrum of SCN2A-associated episodic ataxia |
8 |
| Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome |
8 |
| Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature |
8 |
| A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy |
7 |
| Cognitive functioning in dyskinetic cerebral palsy: Its relation to motor function, communication and epilepsy |
7 |
| Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1 |
7 |
| Basal ganglia mechanisms in action selection, plasticity, and dystonia |
7 |
| Benefits of hippotherapy in children with cerebral palsy: A narrative review |
7 |
| Quality of life of patients with spinal muscular atrophy: A systematic review |
7 |
| A systematic review of comorbidity between cerebral palsy, autism spectrum disorders and Attention Deficit Hyperactivity Disorder |
7 |
| Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study |
6 |
| Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia |
6 |
| A clinical diagnostic algorithm for early onset cerebellar ataxia |
6 |
| Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin |
6 |
| Outcome of isolated agenesis of the corpus callosum: A population-based prospective study |
6 |
| Review of the phenotype of early-onset generalised progressive dystonia due to mutations in KMT2B |
6 |
| Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA(A)R antibodies |
6 |
| Classification and molecular pathogenesis of NBIA syndromes |
6 |
| Pediatric NMDAR encephalitis: A single center observation study with a closer look at movement disorders |
6 |
| Evolution of pediatric epilepsy surgery program over 2000-2017: Improvement of care? |
6 |
| Intracranial hemorrhage in neonates: A review of etiologies, patterns and predicted clinical outcomes |
6 |
| Gait in children with infantile/atypical autism: Age-dependent decrease in gait variability and associations with motor skills |
6 |
| A brother and sister with intellectual disability and characteristic neuroimaging findings |
5 |
| Further delineation of the phenotypic spectrum of ISCA2 defect: A report of ten new cases |
5 |
| A population-based and case-controlled study of children and adolescents with narcolepsy: Health-related quality of life, adaptive behavior and parental stress |
5 |
| Motor function in survivors of pediatric acute lymphoblastic leukemia treated with chemotherapy-only |
5 |
| Effect of rescue medication on seizure duration in non-institutionalized children with epilepsy |
5 |
| The relevance of gene panels in movement disorders diagnosis: A lab perspective |
5 |
| CANS: Childhood acute neuropsychiatric syndromes |
5 |
| A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorder |
5 |
| Failure of ketogenic diet therapy in GLUT1 deficiency syndrome |
5 |
| Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3 |
5 |
| A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype |
5 |
| Early predictors of clinical and mental outcome in tuberous sclerosis complex: A prospective study |
5 |
| Hearing impairment and hypoxia ischaemic encephalopathy: Incidence and associated factors |
5 |
| Safety, tolerability, and effectiveness of oral zonisamide therapy in comparison with intramuscular adrenocorticotropic hormone therapy in infants with West syndrome |
5 |
| Efficacy and tolerability of olive oil-based ketogenic diet in children with drug -resistant epilepsy: A single center experience from Turkey |
5 |
| Two-minute versus 6-minute walk distances during 6-minute walk test in neuromuscular disease: Is the 2-minute walk test an effective alternative to a 6-minute walk test? |
5 |
| Sleep spindle activity in children with obstructive sleep apnea as a marker of neurocognitive performance: A pilot study |
5 |
| Executive function and general intellectual functioning in dyskinetic cerebral palsy: Comparison with spastic cerebral palsy and typically developing controls |
4 |
